This study shows an association between the frequency of the nan1 gene (encoding neuraminidase) among 62 clinical Pseudomonas aeruginosa isolates and adhesion of these bacteria to human buccal epithelial cells. The 52 strains in which the gene was present (83.9%) were characterized by a higher adhesiveness (the mean number of adhering bacteria was 23.51 per cell) than strains in which the gene was not detected (16.23 per cell) and the difference was significant (P = 0.009, Mann-Whitney U test). Thus we found that the nan1 gene may play a role in the binding of clinical P. aeruginosa strains to buccal cells.
INTRODUCTION
Pseudomonas aeruginosa is a major opportunistic pathogen, an important cause of nosocomial respiratory tract infections, and the chief cause of lung infection in cystic fibrosis (CF) (saiman et al. 1992) . Bacterial adherence to mucosal surfaces is a significant aetiological factor in infections. Several in vitro and in vivo studies find poor adherence of P. aeruginosa to functional and intact respiratory epithelia. In contrast, this bacterium is shown to avidly bind to injured epithelia (woods et al. 1980 a, b, 1981 saiman et al. 1992; de Bentzman et al. 1996) . Elevated salivary protease levels in CF patients may modify various cell surface components, such as fibronectin, or expose cryptic receptors for P. aeruginosa (woods et al. 1981) . The ability of P. aeruginosa to persist in the respiratory tract is correlated with the organism ' s ability to adhere to buccal epithelial cells (BECs) (woods et al. 1980 a, b; saiman et al. 1992) . These bacteria adhere readily to trypsinized BECs from healthy individuals, suggesting a similarity between trypsinized BECs and those obtained from CF patients (woods et al. 1980 a) .
P. aeruginosa exoproducts, particularly proteinases and neuraminidase, are noted in many studies to enhance bacterial adherence and to act as virulence factors (Pastoriza & hulen 2006; soonG et al. 2006) . The importance of proteinases in facilitating attachment is substantiated by saiman et al. (1990) . They reported that PAO1 and P1 strains, with detectable proteinases during adherence assay, have the greatest adherence. The increased number of receptors in CF patients who have already been infected by P. aeruginosa might relate to the fact that their cells have been previously exposed in vivo to P. aeruginosa neuraminidase (saiman et al. 1992) . The milieu of CF, especially hyperosmolarity, may specifically activate the expression of several genes (e.g. the neuraminidase nan1 gene) that initiate colonization and facilitate long-term infection lanotte et al. 2003) . P. aeruginosa cells adhere to BECs via pili, which recognize a GalNAcβ1-4 disaccharide exposed in asialylated glycolipids, such as asialo-GM1 (woods et al. 1980 b; saiman & PrinCe 1993; de Bentzman et al. 1996) . Several arguments suggest that the nan1 gene encodes neuraminidase, an enzyme able to release terminal sialic acid residues from sialylated gangliosides, thus increasing the amount of potential bacterial receptors and consequently enhancing adhesion (saiman & PrinCe 1993; lanotte et al. 2003 , 2004 Pastoriza & hulen 2006) . The removal of sialic acid residues from cell surface proteins also results in higher cell-to-cell contact, presumably by enhancing protein-protein interactions through reduction of the net negative surface charge of one of the distinct features of sialic acid (sun et al. 2001) .
In the present study, the nan1 gene encoding neuraminidase was investigated for its role in the adhesion of clinical P. aeruginosa strains to human BECs.
MATERIAL AND METHODS

Bacterial strains
A total of 62 strains of P. aeruginosa were originally isolated from a variety of clinical specimens: faeces (26), urine (12), wound swabs (9), bronchial washings (8), and individual strains obtained from blood, sputum, throat swab, ulceration swab, swab from skin around tracheotomy, and from ear. The bacteria originated from 62 patients from various wards of the municipal hospital, main hospital, and outpatients' department in Siedlce (Poland), between December 2005 and March 2006. The strains were identified as P. aeruginosa on the basis of typical morphology by Gram-negative staining, a positive oxidase reaction, growth at 42 o C, and using the Api 20NE system (bioMérieux, France).
Identification of the nan1 gene
The frequency of the virulence gene encoding neuraminidase (nan1) was determined by PCR (LANOTTE et al. 2004) . Amplification was performed with specific primers nan1-F (5�-ACGCTCCGTCCAGCCGGA-3�) and nan1-R (5�-GTCT-GGACGACGGCGGCA-3�), yielding a 221-bp product. The PCR mixture contained PCR buffer (10 mM Tris/HCl, 50 mM KCl, 1.5 mM MgCl 2 , pH 8.3), 200 µmol of each dNTP (Boehringer, Germany), 0.0125 mmol of each primer, DMSO at a final concentration of 4%, 1 U of AmpliTaq DNA polymerase (Perkin Elmer, USA), and 25 ng of DNA template. The DNA was amplified in PTC-100 Programmable ThermoController (MJ Research, USA) using the following protocol: 94°C for 3 min, 30 cycles of 94°C for 30 s, 55°C for 1 min, and 72°C for 1.5 min, and finally 72°C for 5 min. PCR products were separated in 1% agarose gel for 1 h at 100 V, stained with ethidium bromide, and detected by UV transillumination.
P. aeruginosa adherence to human BECs
Adherence was assayed by the method of Woods et al. (1980 a) . BECs were obtained by vigorous swabbing of the buccal mucosa of healthy, non-smoking people, with a sterile, cotton-tipped swab. The cells were suspended in phosphate-buffered saline (PBS), pH 7.4, and washed 3 times by centrifugation (10 min at 150 g) to remove unattached bacteria. A total cell count was then determined employing a haemocytometer. The concentration of BECs was adjusted to 2.0 × 10 5 cells per ml. Bacteria were grown at 37°C in tripticase soy broth (TSB) (Difco, USA) overnight, pelleted by centrifugation, twice washed in PBS, pH 7.2, and resuspended to a concentration of 10 8 colony-forming units/ml. The BEC suspension and bacterial suspension were mixed and incubated at 37°C for 30 min. After incubation, bacteria and BECs were again washed 3 times with PBS. Smears were made, air-dried, fixed in methanol, and stained with Giemsa staining solution. The number of bacteria adhering to BECs was counted under a light microscope. In each experiment, the first 30 well-defined epithelial cells were observed. Three independent trials were used to calculate the mean number of bacteria adhering to cells in each experiment.
Statistical analysis
The frequency of the nan1 gene among P. aeruginosa strains isolated from different biological materials was examined statistically using chi-square test (P ≤ 0.05). The association between the frequency of the nan1 gene among P. aeruginosa isolates and adhesion of these bacteria to human BECs was studied by the Mann-Whitney U test (P ≤ 0.05).
RESULTS AND DISCUSSION
The nan1 gene is one of many virulence factors that can play an important role in the pathogenesis of P. aeruginosa infection (antonov et al. 2010) . endimiani et al. (2006) reported that the nan1 gene was detected in 57.9% of P. aeruginosa isolates, causing bloodstream infections. Our study confirms the observations of these authors: 52 (83.9%) from 62 of hospital P. aeruginosa strains carried the nan1 gene.
There was no significant difference in the frequency of this gene among P. aeruginosa strains isolated from different sources (P = 0.053). The nan1 gene was detected in 100% of strains isolated from faeces, 50% of strains from bronchial washings, 88.9% of strains from wound swabs, 66.7% of strains from urine, and 85.7% of single strains from other sources. The analysis showed that there is a significant difference in adhesion to BECs between the group of P. aeruginosa strains in which the nan1 gene was present and the group of strains in which the gene was not detected (P = 0.009). Significantly higher adhesion was observed when the gene was present (a mean value of adhesion was 23.51) than when the gene was absent (Fig. 1) (1992) demonstrated that the P. aeruginosa neuraminidase was 1000-fold more active than the C. perfringens enzyme in releasing sialic acid from respiratory epithelial cells. This effect correlated with the increased adherence of PAO1 cells to epithelial cells after exposure to PAO1 neuraminidase. Our previous study (wolsKa et al. 2005 ) demonstrated that the binding of P. aeruginosa strains isolated from humans and different animals to BECs was significantly reduced in vitro in the presence of the neuraminidase inhibitor, 2,2-dehydro-2-deoxy-N-acetyl-neuraminic acid (DANA). The greatest degree of inhibition by DANA was seen on the samples with the highest levels of adherence of control, suggesting that this high control may have been a result of neuraminidase-induced exposure of increased asialo receptors. soonG et al. (2006) reported that the PA2794 neuraminidase locus (Delta 2794) mutant of P. aeruginosa PAO1 was unable to colonize the respiratory tract. They suggest that inhibition of bacterial neuraminidase could provide a novel mechanism to prevent colonization of the respiratory tract by this important pathogen. A recent report showed that when the gene encoding neuraminidase is knocked out, it leads to a reduction in biofilm production in the lungs of mice, and it was suggested that the enzyme recognizes pseudaminic acid, a sialic acid analogue (xu et al. 2009 ).
The results of this study show that Pseudomonas aeruginosa strains adhere much better to BECs carrying the nan1 gene than to BECs lacking the gene. This suggests an important role of the nan1 gene in the pathogenesis of P. aeruginosa respiratory infections.
